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Abstract
The cancer burden in developing countries like Yemen is significant. These
countries are presently ill equipped to adequately provide quality cancer control and care
because they have limited financial and medical resources. The first steps to necessary to
adequately control the eminent cancer crisis in these countries is to initiate sustainable,
cost-effective cancer control strategies. This includes the development of a national
cancer control framework, enacting preventative educational programs, increasing
biomedical treatment capacity, addressing the need for patient empowerment, and
training a significant number of medical professionals. These initiatives can be
successfully implemented and supported by networks between various aspects of cancer
control in developing nations like Yemen and international cancer control experts,
governmental and non-governmental organizations and patient services around the globe.
Networking with countries that have a high quality of cancer control such as Switzerland
is useful so that developing nations have a model by which to develop their own, similar
cancer control strategies.
Introduction
An interest in health and humanity
I have never visited a developing nation, and I have never seen firsthand the
medical, financial or social hardships that citizens of low and middle-income counties
endure daily. However, I have witnessed through my program of development studies
and public health in Geneva the enormous development discrepancies that exist between
industrialized and developing nations, and the ethical issue that these discrepancies create
has personally moved me.
The bulk of my education has been in the natural sciences and I have completed
courses in the biology and genetics of cancer as a disease during my undergraduate
3

studies. Never until this experience have I considered the paramedical and ethical aspects
of cancer, and the social and economic toll that this disease takes on a community. For
communities with few medical and paramedical resources cancer treatment is
functionally inadequate. The disproportionality between cancer care in developed and
developing nations is a humanitarian issue. In terms of human rights, it is unethical for
citizens affected by cancer in industrialized countries to have available a plethora of
resources available to them while citizens of developing nations have little to no medical
access.
Unfortunately, millions of people do not have access to even the most basic of
sanitary conditions and medical attention throughout the world. In those countries where
medical access is limited, the public health infrastructure and cancer control initiatives
are severely lacking, and millions of people die every day due to these inadequacies. The
inequality in health care between industrialized and developing countries is so significant
that this lack of access to cancer care in developing countries becomes an ethical,
humanitarian issue that I feel very passionately can be remedied by partnerships between
non-governmental organizations and health professionals in industrialized and developing
nations.
Through this research I have found that every aspect of cancer control and care in
the developing world needs significant attention, and must utilize all available resources.
Because resources are so scarce and the care system is so detrimentally unstructured, any
work done must begin from the ground by building the most basic public health
infrastructure and empowering patients to rally for change. These initiatives must address
all aspects of cancer care, including psychological and whole-body care to integrate a
human factor into the cancer care system in developing nations. This type of
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humanitarianism must be formulated to address the weak areas of cancer control in
developing nations without neglecting the human interests, values and the dignity of
those people in developing nations. Humanitarian aid to promote this type of
development must originate from partnerships for the promotion of health and
development between industrialized countries, international cancer groups and
developing nations.
For this project I have explored the level of cancer control in an industrialized
country in comparison to that in an underdeveloped country with few resources and little
public health infrastructure, using Switzerland and Yemen, respectively, as illustrations
of these circumstances. Through a comparison of the cancer control situation in these two
countries I will be able to identify the disproportionalities in the level of care between the
two countries, and the specific areas cancer control within the Yemeni public health
sector that are lacking. The ultimate goal of this project is to determine ways that
countries like Switzerland and Yemen can create a bilateral relationship to allow for the
capacity building in the Yemeni public health sector to improve the overall quality of
cancer control and decrease cancer mortality.
Description
Cancer: a global health crisis
In the next several decades the demographic of the world’s population will
significantly change. The number of people between the ages of 60 and 80 years of age
will increase several fold. This shift is presently occurring in more developed nations, but
is not expected to occur in developing nations for several more years. As these countries
progress in development, the average life expectancy will increase significantly. As this
demographic shift occurs, those countries face the burden not only of progressing
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developmentally but also face the burden of an increase in the number of people suffering
from chronic diseases that typically occur as the human body ages. One of the most
prominent diseases, possibly the most eminent disease burden, is that of cancer.
The number of people presently living with cancer is 24.6 million 1 , the majority
of which reside in developing nations. In 2003 the World Health Organization (WHO)
released statistics that forecasted that developing countries would experience a significant
increase in cancer incidence over the next fifteen years. 2 As populations age and chronic
diseases like cancer become progressively more prominent, these developing nations
must create and manage public health initiatives and policies in response to the growing
number of people suffering from the disease.
In industrialized countries, cancer is a large health concern and affects a
significant proportion of the population. However, these developed countries are better
equipped in terms of public health infrastructure, technology, and treatment and care to
deal with the growing cancer crisis. Switzerland, an industrialized country in the heart of
Europe, has a particularly successful cancer control approach. Medical access is granted
to all residence through a social health policy approach, treatment methods are modern
and advanced, an excess of trained cancer specialists exist and cancer care in general is a
whole body approach.
Yemen, a small country in the Eastern Mediterranean Region of the globe,
provides a clear illustration of a developing country dealing with the double burden of the
prevalence of communicable disease like malaria as well as non-communicable diseases.
At present the public health sector of Yemen is ill equipped to deal with the eminent

1

World Health Organization and International Union Against Cancer, Global Action Against Cancer
(Geneva: World Health Organization, 2005), 1.
2
Teleconference interview with D. Malin and M.S. de Sabata, PACT: Yemen officers, International
Atomic Energy Agency Program of Action for Cancer Treatment, Vienna, Austria, 21 November 2008.
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cancer epidemic, and has few medical resources available and very little funding allotted
for prevention, treatment and public health programs.
Methodology
It is possible and efficacious to use the cancer control methodologies utilized in
industrialized countries such as Switzerland as a guide to identify the deficiencies in the
cancer control initiatives that presently exist in developing nations like Yemen. A
comparison of the cancer control approaches of these two nations can be useful in then
determining what areas of cancer control in the public health sector of Yemen need
significant improvement to adequately respond to the growing and eminent cancer
epidemic.
An important pillar of humanitarianism is cooperation between developed and
industrialized countries to promote development. With this development comes improved
health and the acknowledgement of the human aspect of health and health care. It is the
responsibility of those financially and developmentally advanced countries to form
cooperative humanitarian partnerships with developing nations to improve global health
and humanity.
Through proactive partnership between non-governmental organizations and
health care professionals it is possible for the public health sector of Switzerland to aid in
the improvement of cancer mortality in developing countries like Yemen. Various actors
within the Swiss public health sector can proactively share knowledge, technology, talent
and public health infrastructure strategies with nations struggling to control cancer.
Through a micro-study of the cancer control strategies of Switzerland and Yemen I will
identify specific ways in which Switzerland and Yemen can work together to
significantly reduce cancer mortality in Yemen.

7

It is important to recognize that there is a significant disproportionality in the
level of cancer control in an industrialized country and a developing country. This is due
to a large gap in the actual level of political and socioeconomic development of these
nations and the quantity and quality of resources available in each nation. It is crucial to
recognize that there are certain cancer control methodologies that are simply not feasible
options to utilize in a developing nation because of a lack of public health financial
resources available, or a lack of cancer treatment specialists or severely limited access to
essential medicines. For the comparative portion of this project the successful public
health infrastructure that the Swiss cancer control system operates under will be used as
an example of an ideal cancer control approach. From this ideal approach it is possible to
determine the inadequacies of the present cancer control system in Yemen. It is also
possible to determine the most cost-efficient and realistic aspects of ideal cancer control
to project as public health initiatives that will have the most significant impact on cancer
morbidity and mortality in Yemen and that will preserve the dignity of the Yemeni
people.
In planning cancer control partnerships, it is important also to recognize that
humanitarian gift aid is counterproductive to cancer control. Aid should be planned
according to a “pro-poor” growth strategy, where development assistance is geared
toward providing a community with the means to facilitate their own sustainable
development. 3 In terms of cancer care and control this would include proactive pro-poor
strategies including the exchange of knowledge and the training of personnel between the
two countries in order for the struggling country to build its capacity to control the cancer
epidemic.
3

Prezza, Dorothy, “Evaluation criteria to evaluate project of organizations,” Federation of Swiss-Italian
NGO’s, Lugano, Switzerland, 24 September 2008.
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Cancer: the biology and genetics of an age related public health threat
Globally, life expectancy is expected to reach 75 years by 2050, an increase of 28
years since the 1950’s. By 2050 approximately 1.6 billion people over 60 years of age
will live in the least and middle developing countries. This shift in demographics brings
with it a multitude of age related diseases, shifting the public health focus from
communicable diseases like malaria to acute chronic diseases such as cancer. 4
Environmental factors do play a role in the development of cancer but the main risk
factor of cancer is age, and as the life span of populations increase, naturally the
incidence of cancer will increase. 5
Cancer is defined by an unregulated, uncontrolled proliferation of abnormal cells
that have the ability to spread throughout the body. This can occur in any tissue of the
body. Cancer begins as a genetic mutation in a section of DNA called a proto-oncogene
or a tumor suppressor gene. A proto-oncogene is a section of RNA-encoding DNA,
which, if interrupted, becomes an oncogene, or an abnormal gene, which produces
excessive amounts of or abnormal forms of, proteins involved in cell proliferation and
survival. Tumor suppressor genes are normal sections of RNA-encoding DNA that
produce proteins that regulate cell proliferation and survival. If this section of DNA is
interrupted, abnormal proteins are produced in the cell and cell proliferation and survival
continues without regulation. Some cancer cells have been mutated in a way to allow the
cells to divide without the presence of growth signals, or in the presence of growth
inhibitory signals, or in a way that allows the cells to escape regular cell death. As a
result, cancer cells proliferate unregulated and aggregate within the tissue. This

4

Stephanie Lachapelle, Literature Review Essay: Cancer: Challenges for prevention, control, and
treatment in Yemen, School for International Training, 13 October 2008, 3.
5
Interview with Dr. A. P. Sappino, medical oncologist, Hopitaux Universitaires de Geneve, Geneva,
Switzerland, 14 November 2008.
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aggregation is called a tumor. These aggregates build up blood supply by some unknown
mechanism and thrive off of the host tissue. 6
The genetic mechanism behind the development of cancerous cells is what makes
cancer typically a disease of the aged population. Each time the cell goes through the
division cycle, there is a small chance that a mutation will occur in a proto-oncogene or
tumor suppressor gene. With an increase in age comes an increase in the number of
cellular division cycles, and therefore an increase in the probability of a gene mutation
occurring. Fortunately, cancer is a “two hit” phenomenon, and requires two gene
mutations to allow the cell to proliferate uncontrollably and metastasize. 7 The
acquirement of two cancer-causing genetic mutations generally occurs over a period of
several years, and consequently cancer usually occurs in older populations more
frequently.
The aspect of cancer that makes it such a dangerous disease is that the process of
tumor development takes place over a period of several years. The first multiplication of
this cell doesn’t produce a detectable tumor, and therefore it is not until millions of
uncontrolled cells develop that a tumor is visible or biologically detectable. Essentially,
cancer is a disease that can be detected and treated only in later stages of the disease. 8 If
left untreated the cancerous cells will continue to multiple until the tumor mass prohibits
some necessary biological function like respiration or blood circulation and the person
dies.
Cancer is diagnosed according to the stage at which it is discovered. In later
stages, with invasion of surrounding tissues by abnormal cancer cells or with metastases,
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Literature Review Essay: Cancer: Challenges for prevention, control, and treatment in Yemen, 3.
Dr. Roger Denome, e-mail message to author, October 3, 2008.
8
Interview with Dr. Daniel Speiser, Onco-immunologist, The Ludwig Institute for Cancer Research,
Lausanne, Switzerland, 19 November 2008.
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cancer is less amenable to treatment. These cancers require more complex, tailored
chemotherapy treatment and are usually less responsive to radiotherapy treatment. The
longer the time period is between the formation of the tumor and the commencement of
treatment, the more difficult the cancer will be to treat. As time progresses in the
development of cancer, the prospect of successful treatment of the cancer decreases.
There exist three main biomedical treatments for cancer- surgery, chemotherapy
and radiotherapy. Cancer treatment typically involves a combination of these methods to
successfully remove tumor mass and to kill cancerous cells. Surgery involves the removal
of the tumor mass. Chemotherapy is a treatment by which cyto-toxic chemicals are
introduced to the body to interfere with the cell’s ability to proliferate, killing the cells. 9
Chemotherapy medications are prescribed according to guidelines specific for each tumor
type, which are adapted on an individual basis. 10 Radiotherapy treatment involves the
treatment of the tumor directly by a beam of ionizing radiation, which causes the death of
the cancer cells. Radiotherapy is given in short daily doses according to standardized
protocols developed from clinical testing. 11 To effectively kill cancer cells both
radiotherapy and chemotherapy treatments are given in uninterrupted cycles because both
treatments act on cancer cells during division, which happens more often in cancer cells
than in normal tissues. 12
Cancer control in Switzerland and the Republic of Yemen: a stark contrast
Swiss cancer control: a successful strategy
Cancer control in industrialized countries is successful because of a wellestablished public health infrastructure, the availability of health insurance schemes,
9

Ibid, 19 November 2008.
Interview with Dr. A.P. Sappino, 14 November 2008.
11
Interview with Shelley Bulling, physicist, The Centre Radio-oncologie de Geneve, Geneva, Switzerland,
11 November 2008.
12
Interview with Shelley Bulling, 11 November 2008.
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methods of prevention, modern and technologically advanced treatment methods, and a
sufficient pool of specially trained cancer professionals. In Switzerland in particular
cancer control strategies are markedly successful for various reasons.
Switzerland is a rich, developed country in the heart of Europe. Because of the
level of development of this country, the shift in age demographic is presently occurring
and the population as a whole is living longer. Therefore several types of cancer are noted
in the top ten causes of death for all ages. In 2005, approximately sixteen thousand
people died of cancer. Breast and prostate cancer caused the most significant cancer
burden for Swiss women and men. 13 Although cancer is still a significant cause of death
in Switzerland, the Swiss healthcare system has been successful in responding adequately
to the growing incidence of cancer because of the country’s cancer control strategies.
Swiss public health infrastructure
As an industrialized country, Switzerland has a particularly well-established
public health infrastructure. Firstly, the Swiss healthcare system has established a system
of compulsory health insurance that ensures that each person registered as a resident of
any Swiss canton receives basic healthcare at a small premium. If a person is unable to
afford this basic insurance government subsidies will pay for the insurance. Each person
pays the same premium for the same insurance benefits. 14 This ensures access to essential
medical services for chronic disease such as cancer, and includes services such as regular
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World Health Organization, “Impact of Cancer in your country: Switzerland,” World Health
Organization,
http://www.who.int/infobase/report.aspx?rid=119&iso=CHE&generateReport=Generate+Report (accessed
21 November 2008.
14
Dr. Uwe E. Reinhardt, “The Swiss Health System Regulated Competition Without Managed Care.”
JAMA 292 (2004): 1227.
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medical consultations, chemo- and radiation therapy and diagnostic imaging and
laboratory testing. 15
Prevention
Secondly, prevention, education and early detection campaigns are successfully
implemented according to existing epidemiological data that determine the most
important and burdensome cancer incidences in the country. The existence of this
epidemiological data, compiled based on cancer registries, is essential in planning
preventative and educational campaigns to successfully decrease cancer incidence.
Prevention in industrialized countries is practiced in two different forms-primary
and secondary methods of prevention. Firstly, unique to Switzerland and other
industrialized countries is a type of genetic testing that identifies various genetic factors
in a patient’s genetic makeup that may predispose them to developing certain types of
cancer. 16 The genetic factors that are identified are those mutations within tumor
suppressor genes or proto-oncogenes that contribute to the development of cancer.
Through this identification process a program of prevention can be enacted to stop or
retard the development of cancers with those characteristic gene mutations. This is called
primary prevention. 17
Various methods of secondary prevention are also successfully utilized in
Switzerland and other industrialized countries. Breast self-exams, for example, are
promoted by various public health campaigns. These campaigns promoted by services
such as the Ligue Contre le Cancer and the English Speaking Cancer Association in
Switzerland also raise awareness about the symptoms and warning signs of various

15

Interview with Marie Dominique King, oncologic nurse, Ligue Genevoise Contre le Cancer, at the
Espace Mediane, Geneva, Switzerland, 7 November 2008.
16
Interview with Dr. A.P. Sappino, 14 November 2008.
17
Ibid, 14 November 2008.

13

cancers. 18 As Dr. Sappino, head of the oncology department of the Hopitaux
Universitaires de Geneve (HUG) in Geneva, explained,
“Mainly cancer secondary prevention [exists] for breast, cervical, colon,
and skin cancer. These are campaigns that are promoted by health
services…and are recommendations that are put to general practitioners…
For instance, [for] breast cancer screening, there is an official campaign
that promotes regular mammogram in women, between fifty and
seventy…most women here in Geneva will get mammograms because
their doctors will promote the realization of this test on a regular basis.
The same goes for cervical cancers. Most women here have regular
gynecological consultations. The same goes for colon cancer. A
colonoscopy is more and more realized in the majority of the fifty-yearolds, which is a general recommendation. And also general practitioners
are also aware that if you have a family history your risk is higher so
either do the gene testing or do more often screening.” 19
In terms of promoting primary and secondary prevention strategies, hospitals, various
anti-cancer leagues and support groups, and general medical practitioners are all
involved. The involvement of all available resources are necessary to significantly raise
awareness about the prevention of and screening for cancer in order to control the
growing number of incidences. Additionally, because early stage cancers are easier to
treat using standard methods and are more responsive to treatment, early screening tests
like mammograms and colonoscopies to detect cancer in the earliest stage of
development are essential to reduce cancer mortality.
Treatment and care
Treatment in industrialized countries is standardized according to medical
protocols that are adapted to treat each specific type of cancer. The public health sectors
in industrialized countries like Switzerland have recognized that cancer affects the
biological health of the patients but also has a significant affect on the emotional well
being of the patient. Many cancer treatment regimens include not only biomedical
18

Interview with Megan Hamilton, administrator, The English Speaking Cancer Association, at the
Ecumenical Center, Geneva, Switzerland, 6 November 2008.
19
Interview with Dr. A.P. Sappino, 14 November 2008.
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treatment but also psychological counseling in order to control cancer through a wholebody approach.
These types of treatments are available in two major settings- public and private.
In both public and private care facilities the same types of biomedical treatments are
available to patients who hold LAMAL basic Swiss insurance. 20 A person is diagnosed
with cancer through a series of tests to determine the presence, type and stage of the
cancer, and then is referred to a biomedical treatment facility of their choice to obtain
biomedical treatment. The only difference between public and private care is the level of
comfort of the patient and the degree of individualized attention received by the patient,
both of which are at a higher quality in a private setting.
In a pubic facility such as the HUG, a patient is treated by a team of doctors and
cancer specialists to obtain well-rounded care. Included in this team is the oncologist
assigned to that patient, a registered oncologic nurse and a psychologist. The patient
receives nuclear imaging scans such as a CT scan of the part of the body in which the
tumor is located, and from this scan and various pathology tests a treatment regimen is
determined. Most hospitals have an oncology department and a radiology department that
work closely together to provide treatment for patients. 21 To determine a course of
treatment in a Swiss facility, as Dr. Mahmut Ozsahin of the Centre Hospitalier
Universitaire Vaudois (CHUV) explained,
“The surgeon presents this in tumor boards for different disease types. For
example for colorectal cancer, when a surgeon has the diagnosis he or she
presents the patient. So we are discussing together, radiation oncologist,
medical oncologist, proctologist, diagnostic radiologist, surgeon, to
discuss what we will do so according to evidence based medicine we
choose the best treatment. So no one can choose their own treatment.”22
20

Interview with Shelley Bulling, 11 November 2008.
Interview with Dr. A.P. Sappino, 14 November 2008.
22
Interview with Dr. Mahmut Ozsahin, radio oncologist, Centre Hospitalier Universitaire Vaudois,
Lausanne, Switzerland, 18 November 2008.
21
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This method of treatment ensures that the most effective course of treatment is
carried out.
In terms of the actual treatment methods, the Swiss have access to some of the
most specialized equipment and medicines available to provide high quality treatment.
For example, in the Centre de Radio-oncologie de Geneve, a private clinque in Geneva, a
CT scanner, which comes at a cost to the facility of approximately 3 million Swiss
Francs, is used to image the tumor prior to the administration of radiation so that “every
single treatment, no matter how simple, is based on an individualized geometry,” and that
“the radiation is tailored to just cover where we need to cover and not elsewhere with the
idea that it could reduce the side effects.” 23 This technique is used to avoid unwanted side
effects and to improve the comfort of the patient. Typically in industrialized countries an
external beam linear accelerator is used to deliver the radiation to the pre-determined
geometrical area, which comes at a cost of approximately 4 million Swiss Francs. 24 The
CHUV, a public facility in Lausanne, utilizes a special form of modern radiotherapy
software, previously used by the ARMY to track missiles, to optimize radiation treatment
by using inhomogeneous beams. Essentially this high-tech piece of equipment plans the
most effective route of radiation beams to improve the efficiency of treatment. The Swiss
can also utilize basic forms of chemotherapy as well as the most advanced and modern
types of chemotherapy treatment available. This includes immunotherapy and novel
target therapy drugs that are developed to target specific molecular traits of cancer cells.
To provide additional comfort for the patient, agencies exist to allow cancer
patients to receive certain types of treatment in their own home. Oncologic nurses
accompany these patients during the day and night to provide both company and medical
23
24

Interview with Shelley Bulling, 11 November 2008.
Ibid, 11 November 2008.
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supervision. Often home care is utilized during end-of-life palliative care, when a cancer
is at such a late stage that it no longer responds to conventional treatment.
A third and hotly debated aspect of overall cancer care involves addressing the
emotional and bodily toll that the disease takes on the patient. This includes integrating
psychological and nutritional care into cancer treatment. Every health professional
interviewed for this project agreed that psychological care was a necessary and perhaps
underutilized aspect of cancer care. As Monique Noelte, a retired oncologic nurse and a
practicing complementary therapist explained, “To treat cancer on a wide scale first is to
find the origin or at least some of the factors that make the illness to declare itself. We are
in a society that we treat but we don’t focus on the origin, whereas for me I think it is
most important.” She believes that cancer takes an immense emotional toll on the body
and mind, and that suffering can accelerate the illness. Although this may not be
scientifically proven, Ms. Noelte has found through her practice that patients who receive
psychological treatment have more successful cancer treatment outcomes. 25
Ms. Noelte also strongly supported the notion that nutrition has a significant
impact on cancer treatment outcomes. Although this was not necessarily supported by all
of the interviewed cancer specialists, the issue has been debated in various sources and
has gained a significant amount of support. There does exist a wealth of information to
link certain substances like saturated fats to cancers of the intestine, for example, but
nutritional practices have not been fully integrated into routine cancer treatment. 26 To
adequately address nutritional and psychological needs, complementary therapists like
Ms. Noelte are available in Switzerland, and support groups and cancer organizations like

25

Interview with Monique Noelte, retired oncologic nurse and practicing complementary therapist, in her
home, Geneva, Switzerland, 12 November 2008.
26
Dr. Jean Seignalet, L’alimentation ou la troisieme medecine, 4th ed. (Francois-Xabier de Guibert, 2001),
408.
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the Ligue Genevoise Contre le Cancer and the English Speaking Cancer Association
(ESCA) exist to provide support throughout treatment.
Learning Statement
Because Switzerland as a society has recognized the impact that cancer has on a
person and their community, the interest in oncology has increased in the past several
years, and “the extra-hospital network is completely saturated” with cancer health
professionals. 27 These medical and public health professionals have succeeded in
developing over time a public health infrastructure adapted to meet the medical and
financial needs of cancer patients in Switzerland.
The Swiss have a very holistic approach to healthcare, and this is especially
evident in the cancer care system. The healthcare system is structured so that the
biomedical health needs of all Swiss patients are met, so the system can therefore focus
on the whole body and the human aspect of healthcare. By providing psychological
support for patients, either through hospital or facility provided care or through outside
support groups, the Swiss healthcare has recognized that the individual cancer burden
exceeds biomedical limits. Psychological care addresses the feelings of the patient but
also indicates the need to preserve the dignity of the patient. The existence of
complementary therapies provides an outlet for patients to share their experiences and to
address any personal difficulties that they have had in the past that affect their present
health status.
Prior to this research I focused my attention on only the biomedical aspects of the
cancer burden, but I have learned that complementary therapies and a holistic approach is
the most successful and comprehensive cancer control and care strategy. A person is not
simply an aggregate of cells and tissues- people have interests and values, and when
27

Interview with Dr. A.P. Sappino, 14 November 2008.
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affected by a disease like cancer the whole person must be treated. Cancer takes a toll not
only on the cells and the physical self; it takes a significant toll on the mind and the spirit.
By providing access to individualized biomedical treatment options and by providing
whole-body cancer care the Swiss system of cancer control has achieved a superior level
of both quantity and quality of care that is more than adequate for responding to the
number and needs of Swiss cancer patients.
Yemen: an insufficient response to a public health threat
Yemen is small country dealing with the double, or perhaps triple, burden of
responding to outbreaks of communicable diseases such as malaria and managing the
development of acute cancers, while fighting to end extreme poverty, illiteracy and
hunger. Yemen and other developing countries are low and middle-income countries that
have very few resources and little funding for prevention and treatment of cancer but
experience a very high cancer burden. It is difficult to move cancer prevention and
treatment programs to higher priority on the political agenda when over 200,000 people
are afflicted by communicable malaria and pose an immediate threat to public health and
safety. 28 The people of Yemen generally do not have the financial resources to pay for
expensive treatment, “and this is really one of the barriers for the patients because if they
have to pay for a visit, for an exam, for treatment and they don’t have the resources then
whatever you put in place [in terms of cancer control] nationwide would only benefit that
portion of the population who is wealthy enough to afford it.” 29 This is one of the most
constraining aspects of cancer control in developing countries.
Public health infrastructure

28
29

Literature Review Essay: Cancer: Challenges for prevention, control, and treatment in Yemen, 5.
Teleconference interview with D. Malin and M.S. de Sabata, 21 November 2008.
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Yemen lacks the public health infrastructure and access to medicines and
technology that is required to adequately respond to the needs of the a growing number of
people nationwide living with cancer. A very strong political will exists in Yemen to
improve the cancer control strategies, but the government has done little to generate
change.
Presently there exists only one oncology hospital in the entire country of Yemen,
called the National Oncology Center (NOC) in Sana’a, which was established about five
years ago by the initiatives of a group of doctors and the funding of the government. 30
There exist two cancer registries in Yemen, in the city of Aden and at the NOC in Sana’a,
and enough epidemiological data exists to indicate that the two most important cancers in
Yemen are breast cancer for women and head and neck cancers for men. 31 The medical
workforce in Yemen is limited and the working and financial conditions of the public
health sector are poor. Oncology is relatively new to the medical field in Yemen and the
number of doctors and the knowledge base of the available doctors therefore limit access
to oncologic medical attention.
Prevention
Primary and secondary preventative measures in Yemen are sporadic and nonexistent in some geographical areas. For example, the government in Yemen has signed
and ratified a Framework Convention on Tobacco Control, a framework of action for
governments to fight tobacco-related deaths, in 2007 but implementation of these
frameworks has been inconsistent and sporadic. 32 Additionally, tobacco consumption in
the forms of cigarette smoking and chewing qat, a type of chewable smokeless tobacco, is
widespread within Yemen and often begins at a very young age. The chewing of the qat
30

Ibid, 21 November 2008.
Teleconference interview with D. Malin and M.S. de Sabata, 21 November 2008.
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Teleconference interview with D. Malin and M.S. de Sabata, 21 November 2008.
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plant leads to the development of head and neck cancers because of the harmful
pesticides used on the plant during cultivation and as a preservative. Although these
pesticides are illegal in Yemen, they are smuggled across national borders and used
widely in qat fields because of a discontinuity in the policing of national borders. As a
result of this lack of consistent prevention and education initiatives, the general
population of Yemen is unaware of the symptoms of cancer, and by the time they seek
treatment, their tumors are so advanced that they are not amenable to treatment. 33
Treatment and care
The NOC in Sana’a offers the standard types of biomedical cancer treatment,
including surgery, chemotherapy, and radiation. However, because 75 to 80 percent of
patients present with such late stage cancers that would require long and complex
chemotherapy treatments, surgery and radiation are utilized most often as biomedical
cancer treatment. Presently nuclear imaging technology exists in the NOC to identify and
plan radiotherapy treatments and cobalt-60 radiotherapy technology is utilized to deliver
radiotherapy treatment. There is no concerted program for palliative care, but radiation is
used as a form of palliation of late stage incurable cancers and the Yemeni government is
open to the use of opiate drug derivative such as morphine for palliation of cancer-related
pain. Biomedical cancer treatment obtained at the NOC is free. 34
Because there are so few specially trained medical professionals in Yemen and a
growing number of cancer patients, medical efforts are focused on treating the maximum
number of patients possible. There is a significant lack of oncologic nurses, social
workers and other faculty who typically spend a lot of time with patients in treatment.
Therefore, the overall Yemeni approach to cancer care does not involve a system of home
33
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care, nutritional advising or psychological care. The focus is largely placed on the
quantity of care rather than the individual quality of care because so many patients exist
and utilize such limited financial and medical resources.
Evaluation
Clearly there are several areas of cancer control and care in Yemen that are
detrimentally lacking and lead to inadequate cancer control. Firstly, there is a significant
lack of public health infrastructure, and although the Yemeni government has
acknowledged this growing cancer epidemic, they have proactively done little work to
fight this battle. Prevention strategies are inconsistent and sporadic, and this leads to an
increase in the number of late stage cancers that require more modern, complex
treatments that simply are not available in a poor developing country. This lack of
prevention necessitates the wide use of palliative radiation and the use of pain medication
and is not conducive to improving cancer mortality. The Yemeni healthcare system has
not addressed the biomedical aspect of cancer care and control and has not yet
incorporated any kind of humanistic care into the system. The Yemeni system has not
addressed the needs of the whole person. There is an obvious necessity for health policy
planning and an improvement in the cancer control situation to significantly improve the
quality of life for Yemeni cancer patients.
An assessment of cancer control disproportionalities and a plan for global action
The illustrations of two very different levels of cancer control that Switzerland
and Yemen indicate that there are significant disproportionalities in the quality of cancer
control and care in industrialized and developing countries. There are important
disparities in the areas of public health infrastructure, prevention and treatment and care
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methods that are clearly detrimental to the general health and socio-economic
development of nations like Yemen.
National cancer control planning
In Yemen there is not yet a plan of action for cancer control that has been
finalized or accepted by the government, and many other developing countries lack any
kind of comprehensive cancer control scheme. National cancer control plans provide a
framework of action to address all aspects of the cancer burden. Most importantly, cancer
control frameworks obligate the government to identify cancer as a public health threat
and to follow a set regime to fight this disease. The development and implementation of
these frameworks require priority setting, the education and training of health
professionals, prevention initiatives, 35 and more importantly call for the evaluation of
these frameworks to determine the relevance, cost-effectiveness, and sustainability of
each action towards cancer control. The development of national cancer control
frameworks is the first step toward successful national cancer control.
Planning new action to fight cancer requires the support of donor nations,
development agencies and the civilian population. 36 The most difficult challenge faced
by policy makers attempting to reform cancer policy lies in the actual implementation of
these new policies. A plan without implementation generates no change. In order for new
policy to generate significant results, policy must be goal-oriented and realistic,
comprehensive, and utilizing available resources to cover the most people possible. Plans
that include cost-effective priorities with gradual, stepwise goals have a greater chance of
implementation. Interaction between the policy-setting government and international
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donor states or agencies and stakeholders is essential in the communication of valuable
information and monetary funding. 37
The WHO and the International Union Against Cancer (UICC) have published
guides to aid governments and non-governmental organizations in developing national
cancer control frameworks in developing countries. Together, the governments of
developing nations and various non-governmental organizations can determine the cancer
burden and work to build the public health capacity of these nations to improve cancer
mortality and improve the quality of care for cancer patients. Developing nations can
create networks between local cancer professionals and those parties involved in cancer
control planning in industrialized countries, including medical professionals and non- and
governmental organizations that have had successful cancer planning experiences, to
develop and implement efficient cancer control frameworks. For example, cancer
professionals in Yemen can work with specialists in the WHO Eastern Mediterranean
Regional Office and the UICC to develop cancer control strategies.
Epidemiology
Integral in the cancer control planning process is to establish concrete
epidemiological data that indicate the gravity of the issue at hand. It is only through this
data that relevant cancer control strategies can be initiated. Ms. Maria Stella de Sabata, an
expert on cancer control in Yemen, explained,
“It is paramount that the surveillance and the registration capacity is in
hand so that you can have a more accurate idea not only of the incidence
cases, the new cases, but also what happens to these people, how they are
treated, what stage of the disease do they arrive. Over time you will be
able to see if your interventions in other areas bring about a better
awareness of the population so that they will go to a hospital earlier, so
that you would find patients with a lower stage of the disease. It will also
give indications if you have a hospital registry how the treatment is
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working, so that you will be able to allocate to this or this service if it is
making a difference in the patients or not.” 38
The Swiss government has established the epidemiological data to indicate the most
important cancers. From that data the public health sector has taken specific initiatives in
terms of prevention and treatment to decrease the incidence and mortality due to breast
and prostate cancers through programs like Bosom Buddies, a breast cancer information
and support group run through ESCA. In Yemen, however, epidemiological data exists
but has not been effective in illustrating the severity of the cancer burden.
It is crucial to obtain epidemiological data specific to cancer incidence and
mortality within a certain nation to illustrate the national cancer burden. For these
numbers to effectively illustrate this, they cannot include cancer incidence for
international patients receiving treatment within the country. A hospital based cancer
registry like that in the NOC will not effectively produce data specific to cancer in
Yemen because international patients are treated at the center and are therefore registered
in the system. For a country like Yemen to produce a clear illustration of the number of
new cancer incidences and the mortality related to these cases a population and mortality
based cancer registry must be established. This registry would produce epidemiological
data that would track fluctuations in the number of new cancer cases in the population
and would also, over time, produce a concrete assessment of the impact of newly-enacted
preventative and treatment measured to decrease cancer mortality. This data is necessary
to assess the impact and relevance of new cancer control strategies.
To proactively address this lack of epidemiological data in developing nations the
International Agency for Research on Cancer in Lyon, France, holds a summer school
type of learning conference in Epidemiology and cancer registration for professionals

38

Teleconference interview with D. Malin and M.S. de Sabata, 21 November 2008.

25

each year. The course covers topics integral to establishing and maintaining
epidemiological registries such as finding sources of information, the basic principle of
biostatistics, and quality control and measures of comparability. 39 This program is only
one example to increase the epidemiological capacity of a developing country. Networks
of active knowledge sharing and professional training are essential in increasing the
cancer control capacity of developing countries like Yemen.
Prevention
Also key to cancer control and clearly lacking in developing nations like Yemen
are significant and evidence-based prevention programs to prevent the initial
development of cancer and therefore sustainably improve cancer mortality. It is the lack
of prevention and education programs that results in high cancer mortality because
patients present with late-stage, incurable cancers. For example, 50 to 80 percent of
breast cancer patients in low and middle income countries were in advanced stages of
cancer at the time of diagnosis, compared to only 15 percent of breast cancer patients in
developed nations. 40 It is important when planning preventative measures to keep in mind
the cultural and financial barriers that exist and to implement only relative and effective
forms of prevention. For example, screening and early detection methods like routine
mammography for patients over 50 in countries like Switzerland are utilized to identify
cancer in early stages. While this seems like a cost-effective and easy method of cancer
mortality prevention, a prevention method such as this is not feasible for implementation
in a developing country. Mammography technology is an expensive investment that is
not in the budget of a developing country, and these countries do not have specially
39
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trained professionals to carry out these exams. Different, smaller scale types of
prevention techniques must be utilized.
The most successful and feasible preventative techniques involve educating
people about cancer and the risks of their lifestyle choices. Often people are unaware of
the warning signs of cancer or do not know or understand the dangers of their lifestyle
choices, and therefore seek diagnosis in later stages of cancer and continue to practice
cancer causing habits like smoking. To prevent breast cancer, for example, an educational
program can be implemented in schools to teach young adults about the symptoms of
breast cancer and how to perform a self-breast exam. This will teach young adults the
importance of recognizing cancer and seeking immediate medical attention. These
educational programs can be developed through a partnership between school teachers
and public health professionals in developing countries and organizations like the UICC
to spread knowledge globally. To decrease the incidence of head and neck cancer due to
pesticides used on qat, the national government of Yemen can tighten restrictions on
harmful pesticides and strengthen border patrol and importation. The government can
learn methods of border patrol from the border patrol force of countries like the United
States, which has a particularly strong Mexico-United States border patrol. Although
these types of preventative measures do not produce immediate improvements in cancer
incidence, they are long-term, sustainable means for significantly improving the status of
cancer in Yemen and other developing nations.
Biomedical cancer treatment
In industrialized countries like Switzerland, biomedical cancer treatment is
standardized and typically includes a combination of surgery, radiotherapy and
chemotherapy to kill the cancer cells. This is possible in more developed countries
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because the financial, technological and medical professional resources are readily
available. Because of effective prevention plans, patients in more developed countries
present with tumors in less advanced stages, which are more responsive to various forms
of treatment, and these treatments are widely available in all forms throughout the
country.
Unfortunately this situation is different in less developed nations because of
financial constraints, a lack of trained medical personnel and limited access to medicines.
Patients present with tumors in later stages that would require complex chemotherapy
regimens. Both access to these medicines is extremely limited and medical oncologists, if
available, may not be properly trained to prescribe such a complex treatment. Because
chemotherapy is in many cases not a feasible option for cancer patients in resource
limited developing nations like Yemen, radiotherapy is considered the most effective type
of biomedical cancer treatment. Radiotherapy is significantly more cost-effective and
requires less expertise to administer. 41
There is, however, a significant difference between radiotherapy as used in
developed and developing nations. Firstly, there is a difference in the type of machine
used in each type of country. In Switzerland, for example, the Centre de Radio-oncologie
de Geneve uses an expensive linear accelerator, which requires a stable power supply and
constant, expensive maintenance. This type of machine is not typically used in
developing nations because many do not have a constant electrical power supply and do
not have engineers or parts available for constant maintenance. 42 Instead, cobalt
machines are used. Cobalt machines approximately US$ 480000, as compared to US$1.8
million for a linear accelerator, and are mechanically and electronically simpler. A cobalt
41
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machine requires a new radioactive source every five years but otherwise requires little
maintenance. 43 Both machines effectively deliver radiotherapy, but the cobalt machine is
less expensive and requires much less maintenance.
In a developing nation like Yemen radiotherapy is considered a more costeffective form of biomedical cancer treatment for various significant reasons. Although
the cost to initially invest in radiotherapy technology is high, a large number of patients
will be treated by radiotherapy as outpatients, and the radiotherapy room and equipment
can be used for many years. Therefore the actual cost per treatment or patient is very low
compared to the cost of individual chemotherapy treatments. The cost per dose of
radiotherapy is approximately US$4.87. 44 Because of this low cost, a high quality
treatment can be provided to a large portion of cancer patients, and significantly improve
their quality of life.
Additionally, in developing nations radiotherapy is used much more frequently
for palliation of incurable cancers than in developed nations because patients present with
such late stage cancers. Although radiotherapy or another form of biomedical treatment
cannot necessarily cure these cancers, radiotherapy can significantly reduce the pain
associated with cancer and metastases. Radiotherapy is often the only option for relieving
pain in incurable cancers. 45
Although radiotherapy is available to some extent in countries such as Yemen,
there is still a need for capacity building in this area to adequately establish a
radiotherapy infrastructure significant enough to satisfy the needs of the many cancer
patients. Presently over 5000 radiotherapy units are needed in developing nations to meet
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the needs of cancer patients but only 2200 units are installed. 46 The establishment of
treatment facilities requires governmental support, equipment specification and
procurement, and installation, among various other necessities. It takes about five years
to complete this process. The need for improved radiotherapy capacity in developing
nations is clear, and the time to begin this process is now.
The International Atomic Energy Agency (IAEA) has launched a program called
the Program of Action for Cancer Treatment (PACT), in which they network with various
other anti-cancer organizations and work with the governments of various countries to
improve radiotherapy treatment capacity, among other goals. The IAEA-PACT presently
is working on building cancer control and treatment capacity in Yemen. The IAEAPACT program in Yemen is a PACT Model Demonstration Site, from which other
nations needing cancer control capacity building can use as a model for their work. The
IAEA has involved the Yemeni Minister of Health, the NOC, the UICC, and the WHO,
among other partnerships, to carry out this process. 47 These partnerships are essential to
successfully increasing treatment capacity by providing logistical and financial support
and expertise, and aiding in the development of a national comprehensive cancer control
framework.
Complementary therapy and end of life care
Cancer patients in nations with more developed cancer control and care have
access to psychological, nutritional and complementary medical services such as that
practiced by Monique Noelte because their basic medical needs are sufficiently met. In
countries like Switzerland cancer prevention and screening methods exist and are
practiced by the general population, biomedical treatment is available and accessible, and
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the oncology sector of public health is saturated with trained professionals. 48 Therefore,
focus can be shifted to areas of complementary medicine and sufficient services exist to
meet these additional needs. In developing countries that lack sufficient cancer control,
priority must be placed on providing adequate access to medical attention, prevention and
biomedical treatment to begin to control the cancer epidemic. Unfortunately priority is
not placed on psychological or nutritional services outside of biomedical cancer
treatment.
It is, however, recognized by most oncology professionals that these
complementary therapies play a significant role in overall cancer care, and should not be
left out of a comprehensive cancer control framework. Because financial support and the
attention of medical professionals must be diverted elsewhere, the cancer patients
themselves must be the ones to drive these types of therapies through programs like the
UICC’s Reach to Recovery International. This program is a network of advocacy,
education and patient support for people with breast cancer. Essentially groups like this
empower patients to help themselves and others in similar conditions. 49 Networks
between patients to form these types of groups are essential in providing whole-body type
cancer care.
Groups like these can also aid in building the capacity for non-biomedical end of
life care services. Because the attention of oncologic nurses in developing nations is
required for treatment and treatment is generally an outpatient service, patients are often
not accompanied during the end of life. Patient services like the National Cancer Control
Foundation in partnership with non-governmental organizations can model patient
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service programs after successful organizations like the English Speaking Cancer
Association to address discrepancies in complementary care.
Training of medical professionals
Few cancer control initiatives can be carried out without a sufficient number of
properly trained cancer specialists. In developed nations this is less of an issue than in
developing nations like Yemen. In Yemen specifically working conditions are poor, the
existing staff are overworked, and there are few incentives for trained medical
professionals to stay and work in the country. This drives most of the discrepancies in
cancer control between developed and developing nations. In order to advance care
capacity specific attention must be paid to training professionals and establishing cancer
training networks to generate sustainable training system.
There needs to be a significant increase in the number of professionals training
regionally in cancer so cancer professionals will remain in their country. Successful
training design and implementation involves hospital administration, physicians,
physicists, and oncologic support staff to work towards a common goal in their own
country. 50 Because resources are so limited, removing these staff from their positions for
extended training periods is not conducive to improving cancer control. Distance learning
is one of the most useful tools for training. Presently the IAEA-PACT program is
working to establish a Cancer Control International Mentorship Network, in which
mentor institutions in more advance countries will be partnered with an institution in a
developing nation to exchange multidisciplinary training and research and to provide
ongoing support for the institution in the developing region. 51 This program seeks to
form important networks of knowledge sharing and best-practice mentorship to improve
50
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the cancer control situation in developing nations through the training of cancer
professionals.
The IAEA-PACT program is also working to establish a Virtual Cancer Control
University, to provide access to training techniques and information exchange via the
Internet. This network will allow for the exchange of vital cancer control information and
techniques while keeping professionals in country. 52 This network will link international
experts with local practicing cancer professionals to improve the treatment and control
capacity.
Additionally, fellowships are available through organizations such as the UICC to
financially support the research and training programs of practicing cancer
professionals. 53 These cancer control networks and systems of financial support are
necessary to train cancer professionals that currently practice in developing countries and
to encourage more aspiring medical professionals to practice in developing nations.
These professionals are the people who develop and actuate cancer control initiative and
ultimately are the driving force behind the improvement of cancer control capacity.
Evaluation of these cancer control initiatives
These cancer control initiatives are essential to significantly improve the overall
cancer control situation in developing countries such as Yemen. In order for these
initiatives to proactively drive change, they each must be relevant to the issue at hand,
cost-effective and sustainable in the long term.
Cancer control frameworks and Epidemiology
The development of a comprehensive cancer control framework is perhaps the
most relevant method to improve the quality of cancer control in Yemen and other
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developing countries. The development of these frameworks requires the cooperation of
all parties involved in cancer care, including the government and medical professionals,
and will therefore address all aspects of cancer control. The frameworks will assess the
cancer burden through epidemiological data to identify the most pertinent cancer control
initiatives to carry out, and will also assign these responsibilities to working groups to
actually initiate change. This is the most cost-effective method to address the cancer
control issue because once epidemiological data are collected, problems and areas
needing work are identified, financial support can be allocated accordingly, rather than
sporadically initiating cancer control actions. Cancer control frameworks are, by
definition, short- and long-term goals to successfully implement cancer control strategies,
and therefore this methods are sustainable in the long term. Epidemiological cancer
registries, once established, are an easily sustainable method for assessing the cancer
burden and tracking the success of cancer control interventions.
Prevention
Because patients in developing countries seek treatment in later stages of cancer,
prevention and education programs are the most relevant and effective way to control
cancer. Educational preventative programs implemented in schools are low-cost and will
reach large populations in a short time. Children are the target population in this case
because the most sustainable prevention is to motivate lifestyle change, and this is most
successful at a young age. Additionally, using school programs as a vector, the
information will reach the population in a culturally appropriate manner to empower the
groups at risk and to promote early detection. This method may not have an immediate
affect on the cancer incidence but will have a significant affect on the number of new
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cancer incidences and mortality rate in the future. Educational preventative measures
therefore are relevant, cost-effective and sustainable.
Biomedical cancer treatments
Increasing the treatment capacity of developing nations will have an immediate
affect on cancer mortality because a larger portion of the population will have access to
biomedical cancer treatments. The use of radiotherapy in developing nations is the most
relevant and certainly most cost effective form of biomedical treatment. Developing
nations do not have access to expensive and complex chemotherapy treatments, and
cancers are often found too late to cure. Radiotherapy is a low cost per treatment method
of biomedical treatment that can be administered as an outpatient procedure, and
therefore can be used to treat a large percent of the population of cancer patients.
Additionally, radiotherapy serves an additional purpose in that it is also used in a large
portion of the population to provide palliative care for cancer-related pain. Cobalt
radiotherapy technology requires a substantial initial investment but requires little
maintenance and is therefore sustainable in the long term.
Complementary therapy and end of life care
It is clear that cancer control frameworks must prioritize the needs of a population
and the first actions must address the most pressing cancer control issues. It is debatable
whether complementary therapies and end of life care are truly necessary aspects of
overall cancer care. However, cancer control frameworks should be comprehensive and
address all aspects of cancer control. Although complementary therapies and end of life
care are not priorities, these aspects of cancer care can be addressed through the
establishment of support groups by cancer care non-governmental organizations. This is
the most relevant and cost effective way to address the needs of the population because
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this method does not require the work of those dedicated to providing biomedical
treatments. Once the cancer patients are empowered to help each other, they will drive
their own sustainable networks.
The training of medical professionals
The existence of trained medical professionals is a vital part of controlling the
cancer epidemic. These professionals are not only the people responsible for delivering
cancer care but make up a large portion of the driving force for the improvement of
cancer care capacity. Without trained medical professionals cancer treatment would not
be possible. The training of professionals through in-country networking with
international experts allows for the exchange of technique and knowledge and allows
those professionals to continue to deliver their vital services. This is the most beneficial
way to address the lack of trained professionals in developing nations. More people will
be encouraged to join the cancer control force once obtaining training becomes easier and
less costly.
Conclusions
These global public health partnerships are only the first steps towards holistically
improving cancer control and care in developing nations. These initiatives require
valuable humanitarian cooperation between industrialized nations, international
organizations and developing nations to globally reduce the cancer burden. It is the
human aspect of humanitarianism that creates the global responsibility to respond to and
improve the global cancer crisis.
These public health initiatives are essential to successfully meet all of the needs of
cancer patients in developing countries. These initiatives empower cancer patients and
integrate a systematic pro-poor growth strategy so that humanitarian type aid from more
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developed nations preserves the dignity of the Yemeni people. It is difficult in a crisis
situation for a government to admit that their efforts are lacking or insufficient to meet
the grave needs of their people. By working in partnership with international agencies
and by receiving guided assistance and not gift aid, the Yemeni government, health
professionals and the general population learn to proactively improve their cancer burden.
This plan for action includes partnerships and initiatives to address the
comprehensive needs of the cancer patient in developing nations like Yemen. Because
resources are so limited, cancer control and care in resource-poor nations often focuses
on providing only the essential biomedical treatments to try to cure the illness. From the
illustration of the Swiss healthcare system it is clear not only that curing the illness
should not be the only goal, and also that cancer care involves more than biomedical
treatment. The Swiss example of cancer control and care indicates in its success that each
aspect of the human must be appropriately addressed and treated during the course of the
illness, and this includes treating the mind and spirit. Successful cancer care must focus
on treating the whole human, and not on individual parts. These cancer control and care
initiatives are sensitive to the holistic needs of cancer patients and utilize available
resources to help cancer patients empower each other and improve their own health
status.
Most importantly, these cancer care and control initiatives address the global
humanitarian responsibility to respond to the eminent cancer crisis. It is our responsibility
as human beings to take interest and action in the sufferings of others, and this is the basis
for cancer control humanitarian action. Industrialized countries with successful cancer
control strategies like Switzerland have a humanitarian responsibility to share these
strategies with countries struggling to provide care for cancer patients and to assist in the
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development of cancer control strategies in developing nations. These partnerships are
essential for knowledge sharing to improve the global cancer control status and to spread
successful cancer control initiatives to developing nations to improve the overall global
cancer burden. International cancer control organizations such as the IAEA or the UICC
are integral to the formation of these partnerships and essentially facilitate the
progression of cancer control.
Learning outcomes and further research
Prior to this project my education in the topic of cancer focused on the scientific
aspects of cancer as a disease and biomedical cancer treatments. I had never done
research in the areas of complementary therapy or looked at the socioeconomic aspect of
the cancer burden. Through this research and particularly through my interviews with
Monique Noelte and Daniel Malin and Maria Stella De Sabata I have been exposed to
these alternative and important aspects of cancer control. Cancer control and care must be
a holistic type of treatment because cancer as a disease affects more than just the physical
being. If we approach cancer care with a whole body treatment approach we create a
unique way to fight the disease burden. If we cannot biomedically treat and cure the
disease, we can still treat the other aspects of the individual and significantly improve the
quality of life for the patient. I think that perhaps this perspective is absent from a lot of
cancer control strategies, but that this perspective is particularly important and valuable,
especially in treating a disease like cancer. Biomedical treatment alone does not address
the entirety of the disease burden. In the future I would like to continue to research
complementary therapies and the role they play in comprehensive cancer care, and ways
to significantly improve the psychological well being of cancer patients in both
developed and developing nations.
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I have also learned that there are significant disproportionalities that exist between
developed and developing nations in terms of cancer control and care, and most
importantly that public health infrastructure is the most basic necessity to treat a disease
like cancer. Developing nations are so resource-poor that they lack the public health
structure to put forth any initiatives to respond to health crises, regardless of their will.
Essentially these structures must be built from the ground up, starting with the most basic
structure to build upon to successfully erect a public health sector. These structures as
well as disease control initiatives must be build in small successive steps to have
significant future impact. This is the reason why humanitarian gift-type aid does not
establish sustainable change. This learning outcome is valuable in planning humanitarian
development strategies. We must work together to respond to development and health
crises. Successful disease care and control initiatives must come from our humanitarian
responsibility to assist each other.
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